Jazz Pharmaceuticals plc — Director's Dealing 2013

Mar 12, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-03-12

Reporting Person: COZADD BRUCE C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-12	Ordinary Shares	S	4000	$59.48	Disposed	623161	Direct
2013-03-12	Ordinary Shares	S	1000	$60.00	Disposed	622161	Direct

Footnotes

F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.